Bryn Mawr Capital Management LLC Sells 23,709 Shares of The Chemours Company (NYSE:CC)

Bryn Mawr Capital Management LLC trimmed its holdings in shares of The Chemours Company (NYSE:CC) by 89.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,756 shares of the specialty chemicals company’s stock after selling 23,709 shares during the quarter. Bryn Mawr Capital Management LLC’s holdings in Chemours were worth $47,000 as of its most recent filing with the SEC.

A number of other large investors have also bought and sold shares of CC. Creative Planning increased its stake in Chemours by 66.6% during the 3rd quarter. Creative Planning now owns 44,228 shares of the specialty chemicals company’s stock worth $899,000 after purchasing an additional 17,682 shares in the last quarter. Blue Trust Inc. increased its stake in Chemours by 166.9% during the 3rd quarter. Blue Trust Inc. now owns 1,169 shares of the specialty chemicals company’s stock worth $26,000 after purchasing an additional 731 shares in the last quarter. Signaturefd LLC increased its stake in Chemours by 163.7% during the 3rd quarter. Signaturefd LLC now owns 1,959 shares of the specialty chemicals company’s stock worth $40,000 after purchasing an additional 1,216 shares in the last quarter. International Assets Investment Management LLC bought a new position in shares of Chemours during the 3rd quarter worth approximately $4,110,000. Finally, State of Alaska Department of Revenue grew its stake in shares of Chemours by 7.3% during the 3rd quarter. State of Alaska Department of Revenue now owns 17,205 shares of the specialty chemicals company’s stock worth $349,000 after acquiring an additional 1,175 shares in the last quarter. 76.26% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

CC has been the subject of several research reports. BMO Capital Markets decreased their price target on shares of Chemours from $34.00 to $27.00 and set an “outperform” rating for the company in a research note on Wednesday. Mizuho decreased their price target on shares of Chemours from $22.00 to $21.00 and set a “neutral” rating for the company in a research note on Tuesday, January 7th. Barclays raised their price target on shares of Chemours from $21.00 to $23.00 and gave the stock an “equal weight” rating in a research note on Tuesday, November 5th. The Goldman Sachs Group decreased their price target on shares of Chemours from $24.00 to $21.00 and set a “neutral” rating for the company in a research note on Tuesday, January 7th. Finally, Truist Financial started coverage on shares of Chemours in a research note on Tuesday, January 28th. They set a “buy” rating and a $27.00 price target for the company. Five investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $23.56.

Chemours Price Performance

NYSE:CC opened at $16.77 on Friday. The Chemours Company has a 1-year low of $15.10 and a 1-year high of $29.83. The company has a current ratio of 1.68, a quick ratio of 0.92 and a debt-to-equity ratio of 6.70. The firm has a fifty day simple moving average of $18.09 and a 200 day simple moving average of $18.91. The stock has a market capitalization of $2.51 billion, a PE ratio of 29.42 and a beta of 1.81.

Chemours (NYSE:CC) last announced its quarterly earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.10 by $0.01. Chemours had a return on equity of 26.54% and a net margin of 1.51%. The business had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.37 billion. On average, research analysts expect that The Chemours Company will post 2.03 EPS for the current fiscal year.

Chemours Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Friday, February 28th will be issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 5.96%. The ex-dividend date is Friday, February 28th. Chemours’s dividend payout ratio is 175.44%.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.